Thrivent Financial for Lutherans Has $5.60 Million Position in Bath & Body Works, Inc. (NYSE:BBWI)

Thrivent Financial for Lutherans lifted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 1,842.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 175,301 shares of the company’s stock after buying an additional 166,277 shares during the period. Thrivent Financial for Lutherans’ holdings in Bath & Body Works were worth $5,596,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of BBWI. Frazier Financial Advisors LLC raised its holdings in Bath & Body Works by 4.2% during the third quarter. Frazier Financial Advisors LLC now owns 41,082 shares of the company’s stock worth $1,311,000 after acquiring an additional 1,645 shares in the last quarter. Mutual of America Capital Management LLC raised its stake in shares of Bath & Body Works by 18.4% during the 3rd quarter. Mutual of America Capital Management LLC now owns 33,429 shares of the company’s stock worth $1,067,000 after purchasing an additional 5,203 shares in the last quarter. Empowered Funds LLC boosted its holdings in shares of Bath & Body Works by 68.0% in the 3rd quarter. Empowered Funds LLC now owns 26,462 shares of the company’s stock valued at $845,000 after buying an additional 10,711 shares during the last quarter. KBC Group NV grew its stake in shares of Bath & Body Works by 9,023.5% in the third quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock valued at $54,322,000 after buying an additional 1,683,160 shares in the last quarter. Finally, Oppenheimer & Co. Inc. increased its holdings in Bath & Body Works by 4.5% during the third quarter. Oppenheimer & Co. Inc. now owns 28,535 shares of the company’s stock worth $911,000 after buying an additional 1,231 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $30.71 on Friday. The firm has a 50-day moving average of $30.55 and a 200-day moving average of $35.91. Bath & Body Works, Inc. has a 52-week low of $26.20 and a 52-week high of $52.99. The stock has a market cap of $6.73 billion, a PE ratio of 7.44, a PEG ratio of 0.98 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. Equities research analysts predict that Bath & Body Works, Inc. will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be issued a $0.20 dividend. The ex-dividend date is Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.61%. Bath & Body Works’s dividend payout ratio is presently 19.37%.

Insider Buying and Selling at Bath & Body Works

In related news, CEO Gina Boswell purchased 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The stock was acquired at an average price of $29.64 per share, with a total value of $177,840.00. Following the completion of the purchase, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.27% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Robert W. Baird cut their price target on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Raymond James dropped their target price on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a report on Thursday, August 29th. Telsey Advisory Group reiterated an “outperform” rating and set a $42.00 price target on shares of Bath & Body Works in a report on Monday, November 18th. BMO Capital Markets restated an “outperform” rating and issued a $50.00 price objective (down previously from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. Finally, JPMorgan Chase & Co. reduced their target price on Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating for the company in a research note on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, Bath & Body Works has a consensus rating of “Moderate Buy” and an average target price of $42.25.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.